These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19918141)

  • 1. The resurgence of granulocyte transfusions.
    Harris DJ
    J Infus Nurs; 2009; 32(6):323-9. PubMed ID: 19918141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
    Hübel K; Engert A
    Onkologie; 2003 Feb; 26(1):73-9. PubMed ID: 12624522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte transfusion: revisited.
    Briones MA; Josephson CD; Hillyer CD
    Curr Hematol Rep; 2003 Nov; 2(6):522-7. PubMed ID: 14561398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
    Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes.
    Drewniak A; Boelens JJ; Vrielink H; Tool AT; Bruin MC; van den Heuvel-Eibrink M; Ball L; van de Wetering MD; Roos D; Kuijpers TW
    Haematologica; 2008 Jul; 93(7):1058-67. PubMed ID: 18508794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value and practicality of granulocyte transfusion: a single oncology centre experience.
    Al-Tanbal H; Al Humaidan H; Al-Nounou R; Roberts G; Tesfamichael K; Owaidah T
    Transfus Med; 2010 Jun; 20(3):160-8. PubMed ID: 20070613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte transfusion therapy.
    Strauss RG
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1159-66. PubMed ID: 7860442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.
    Spitzer G; Deisseroth A; Ventura G; Jagannath S; Fogel B; Taylor K; Huan S; Dunphy F; Dicke K; Souza L
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():249-59; discussion 259-61. PubMed ID: 1691246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony-stimulating factors in the management of neutropenia and its complications.
    Heuser M; Ganser A
    Ann Hematol; 2005 Oct; 84(11):697-708. PubMed ID: 16047204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction.
    Díaz R; Soundar E; Hartman SK; Dreyer Z; Teruya J; Hui SK
    Pediatr Hematol Oncol; 2014 Aug; 31(5):425-34. PubMed ID: 24383443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of biologic response modifiers.
    Louie SG; Jung B
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S10-8. PubMed ID: 7689788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study.
    Kikuta A; Ohto H; Nemoto K; Mochizuki K; Sano H; Ito M; Suzuki H
    Vox Sang; 2006 Jul; 91(1):70-6. PubMed ID: 16756604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils.
    Christensen RD; Rothstein G; Anstall HB; Bybee B
    Pediatrics; 1982 Jul; 70(1):1-6. PubMed ID: 7088606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte transfusions in neutropenic patients: beneficial effects proven?
    Peters C
    Vox Sang; 2009 May; 96(4):275-83. PubMed ID: 19207168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The role of granulocyte transfusions.
    Strauss RG
    Am J Pediatr Hematol Oncol; 1984; 6(3):247-53. PubMed ID: 6393788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.